1. Turner GA, Ellis RD, Guthrie D, et al. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment. J Clin Pathol 1982, 35, 800–806.
2. Random urinary cyclic 3′,5′ guanosine monophosphate in epithelial ovarian cancer: relation to other prognostic variables and to survival;Luesley;Br J Obstet Gynaecol,1986
3. Serial urinary cyclic guanosine monophosphate measurements in the assessment of response to treatment in epithelial ovarian cancer;Luesley;Br J Obstet Gynaecol,1987
4. Cell density-dependence of cAMP and cGMP levels in four human cell lines derived from carcinomas of the uterine cervix;Ørbo;Gynaecol Oncol,1994
5. Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4-I) and non-transformed (WI-38) human cells;Ørbo;Int J Cancer,1993